2023 Keynote Speakers

Olufunmilayo Olopade 2023 CGC Annual Meeting Keynote

Olufunmilayo Falusi Olopade, MD

Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medicine, Dr. Olopade’s research is focused on gaining a better understanding of the root causes and genomic basis of cancer in diverse populations. She has published extensively on genetic and non-genetic risk factors for breast cancer and is internationally renowned for her work in inherited cancer syndromes and clinical expertise in early detection and prevention of breast cancer in high risk women. 

Guillermo Garcia-Manero, MD

Dr. Guillermo Garcia-Manero is the Dr. Kenneth B. McCredie Chair in Clinical Leukemia Research in the Department of Leukemia at the University of Texas MD Anderson Cancer Center. He also serves as the Chief of the Section of Myelodysplastic Syndromes and Vice Chairman of the Department of Leukemia at UT MD Anderson Cancer Center. He also serves as Leader of the MDS/AML Moon Shot Program and Program Director of the Leukemia Fellowship Program at MD Anderson Cancer Center. 

John DiPersio, MD, PhD 2023 CGC Annual Meeting Keynote

John DiPersio, MD, PhD

Dr. John F. DiPersio, Professor of Medicine and Pathology & Immunology, Director, Center for Gene and Cellular Immunotherapy at Washington University School of Medicine in St. Louis and the Virginia E. and Samuel J. Golman Professor of Medicine.  

His research focuses on mechanistic and translational aspects of leukemia and stem cell biology. He has played a key role in the clinical development of plerixafor as a mobilizing agent for stem cell transplantation. 

DAvid Beck, MD, PhD 2023 CGC Annual Conference Keynote

David Beck, MD, PhD

Dr. Beck received his MD/PhD at New York University School of Medicine where he studied biochemistry and cell fate decisions in the laboratory of Dr. Danny Reinberg. He performed further clinical training at Columbia University in Internal Medicine and the National Institutes of Health in clinical genetics. David performed his postdoctoral research with Dr. Dan Kastner at the National Human Genome Research Institute studying the genetics and mechanism underlying a subset of rheumatic diseases called autoinflammatory syndromes.